Safety of Celecoxib in Patients With Ulcerative Colitis in Remission: A Randomized, Placebo-Controlled, Pilot Study
Authors:
- William J. SandbornWSWilliam J. Sandborn
- William F. StensonWSWilliam F. Stenson
- Jørn BrynskovJBJørn Brynskov
- Robin G. LorenzRLRobin G. Lorenz
- Gina M. SteidleGSGina M. Steidle
- Jeffery L. RobbinsJRJeffery L. Robbins
- Jeffery D. KentJKJeffery D. Kent
- Bradley J. BloomBBBradley J. Bloom
- 1 February 2006
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 4 (2) , 203-211
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- An open‐label trial of the selective cyclo‐oxygenase‐2 inhibitor, rofecoxib, in inflammatory bowel disease‐associated peripheral arthritis and arthralgiaAlimentary Pharmacology & Therapeutics, 2003
- Non‐steroidal anti‐inflammatory drugs, aspirin and newly diagnosed colitis: a case–control studyAlimentary Pharmacology & Therapeutics, 2003
- Serious lower gastrointestinal clinical events with nonselective NSAID or coxib useGastroenterology, 2003
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- Basic biology and clinical application of specific cyclooxygenase-2 inhibitorsArthritis & Rheumatism, 2000
- Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparisonThe Lancet, 1999
- Anti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid ArthritisJAMA, 1999
- Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel diseaseGastroenterology, 1998
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987
- Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like DrugsNature New Biology, 1971